Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Intangibles (2022 - 2025)

60 Degrees Pharmaceuticals (SXTP) has disclosed Intangibles for 4 consecutive years, with $258674.0 as the latest value for Q3 2025.

  • On a quarterly basis, Intangibles changed N/A to $258674.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $258674.0, a N/A change, with the full-year FY2024 number at $157084.0, down 30.88% from a year prior.
  • Intangibles was $258674.0 for Q3 2025 at 60 Degrees Pharmaceuticals, up from $149785.0 in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $305261.0 in Q2 2024 to a low of $149785.0 in Q1 2025.
  • A 4-year average of $214420.1 and a median of $226152.5 in 2023 define the central range for Intangibles.
  • Peak YoY movement for Intangibles: surged 38.36% in 2023, then tumbled 30.88% in 2024.
  • 60 Degrees Pharmaceuticals' Intangibles stood at $164255.0 in 2022, then soared by 38.36% to $227258.0 in 2023, then crashed by 30.88% to $157084.0 in 2024, then soared by 64.67% to $258674.0 in 2025.
  • Per Business Quant, the three most recent readings for SXTP's Intangibles are $258674.0 (Q3 2025), $149785.0 (Q1 2025), and $157084.0 (Q4 2024).